Your browser doesn't support javascript.
loading
Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect.
Capitini, Christian M; Herby, Sarah; Milliron, Matthew; Anver, Miriam R; Mackall, Crystal L; Fry, Terry J.
Affiliation
  • Capitini CM; Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. capitinic@mail.nih.gov
Blood ; 113(20): 5002-9, 2009 May 14.
Article in En | MEDLINE | ID: mdl-19258593

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Marrow Transplantation / Interferon-gamma / Receptors, Interferon / Graft vs Tumor Effect / Graft vs Host Disease Type of study: Risk_factors_studies Limits: Animals Language: En Journal: Blood Year: 2009 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Marrow Transplantation / Interferon-gamma / Receptors, Interferon / Graft vs Tumor Effect / Graft vs Host Disease Type of study: Risk_factors_studies Limits: Animals Language: En Journal: Blood Year: 2009 Type: Article Affiliation country: United States